Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.56 EUR | -0.39% | +0.11% | +2.03% |
03/05 | GSK plc : Back on track | |
02/05 | European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading | MT |
Sales 2024 * | 46.24B 49.76B 4,152B | Sales 2025 * | 49.92B 53.72B 4,482B | Capitalization | 114B 123B 10,236B |
---|---|---|---|---|---|
Net income 2024 * | 7.13B 7.67B 640B | Net income 2025 * | 8.66B 9.32B 777B | EV / Sales 2024 * | 2.61 x |
Net Debt 2024 * | 6.56B 7.06B 589B | Net Debt 2025 * | 1.95B 2.1B 175B | EV / Sales 2025 * | 2.32 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
13.2
x | Employees | 86,088 |
Yield 2024 * |
4.21% | Yield 2025 * |
4.46% | Free-Float | 87.12% |
Latest transcript on Sanofi
1 day | -0.39% | ||
1 week | +0.11% | ||
Current month | -1.65% | ||
1 month | +3.18% | ||
3 months | +4.09% | ||
6 months | +7.13% | ||
Current year | +2.03% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 01/19/01 |
Madeleine Roach
COO | Chief Operating Officer | 40 | 01/22/01 |
Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 01/14/01 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 22/20/22 |
Frédéric Oudéa
CHM | Chairman | 60 | 02/22/02 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 91.56 | -0.39% | 1,908 |
02/24/02 | 91.92 | -1.27% | 3,556 |
30/24/30 | 93.1 | +1.78% | 1,063 |
29/24/29 | 91.47 | +0.01% | 1,863 |
26/24/26 | 91.46 | -0.48% | 2,928 |
Delayed Quote Xetra, May 03, 2024 at 09:05 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- SAN Stock
- SNW Stock